The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
wedelolactone inhibits the reaction [Dimethyl Sulfoxide results in increased expression of EDNRB mRNA]; wedelolactone inhibits the reaction [Dimethyl Sulfoxide results in increased expression of EDNRB protein]; wedelolactone inhibits the reaction [Particulate Matter results in increased expression of EDNRB mRNA]; wedelolactone inhibits the reaction [Particulate Matter results in increased expression of EDNRB protein]; wedelolactone inhibits the reaction [Smoke results in increased expression of EDNRB protein]; wedelolactone inhibits the reaction [TNF protein results in increased expression of EDNRB mRNA]; wedelolactone inhibits the reaction [TNF protein results in increased expression of EDNRB protein]
wedelolactone inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein] [wedelolactone results in decreased activity of IKBKB protein] which results in decreased phosphorylation of NFKBIA protein
wedelolactone inhibits the reaction [Methamphetamine results in increased cleavage of PARP1 protein] wedelolactone results in increased cleavage of PARP1 protein Acetylcysteine inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein]; Buthionine Sulfoximine promotes the reaction [wedelolactone results in increased cleavage of PARP1 protein]; CAT protein inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein]; S-ethyl glutathione inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein]
wedelolactone inhibits the reaction [TNF protein results in increased expression of RELA protein] wedelolactone affects the localization of and results in decreased activity of RELA protein; wedelolactone inhibits the reaction [Palmitic Acid affects the localization of and results in increased activity of RELA protein]
[wedelolactone results in decreased activity of SLC22A6 protein] which results in increased susceptibility to and results in increased activity of aristolochic acid I
[wedelolactone results in decreased activity of SLC22A8 protein] which results in increased susceptibility to and results in increased activity of aristolochic acid I
wedelolactone inhibits the reaction [TNF protein results in increased expression of EDNRB mRNA]; wedelolactone inhibits the reaction [TNF protein results in increased expression of EDNRB protein]; wedelolactone inhibits the reaction [TNF protein results in increased expression of RELA protein]; wedelolactone inhibits the reaction [TNF protein results in increased phosphorylation of CHUK protein]; wedelolactone inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein] wedelolactone inhibits the reaction [TNF protein results in increased abundance of Dinoprostone]; wedelolactone inhibits the reaction [TNF protein results in increased abundance of Thromboxane B2]; wedelolactone inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; wedelolactone inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] wedelolactone inhibits the reaction [[Cisplatin co-treated with TNF protein] results in increased phosphorylation of JUN protein]